A spokesman for the European Medicines Agency announced that on Monday it began studying a modified version of the Covid 19 vaccine produced by Pfizer/Biontech Laboratories that targets two submutants of the rapidly spreading Omicron virus. “.

He indicated that the agency expects to receive a request for a modified two-submutant BA.4/5 vaccine in the fall, which will be evaluated for possible rapid approval. He indicated that a decision could be made “soon” after the expected approval of two other modified vaccines made by Pfizer and Moderna that target the original virus and Omicron’s previous submutant, “BA.1.” “.

The two companies filed two separate requests for approval of their vaccines on July 22.

The two Omicron mutants (BA.4) and (BA.5) have caused an increase in Covid 19 infections in both Europe and the United States of America, prompting the UN to announce last month that the epidemic has “subsided”. not finished yet.”